首页> 外文期刊>Journal of vascular surgery >A new method for quantification of false lumen thrombosis in aortic dissection using magnetic resonance imaging and a blood pool contrast agent.
【24h】

A new method for quantification of false lumen thrombosis in aortic dissection using magnetic resonance imaging and a blood pool contrast agent.

机译:一种使用磁共振成像和血池造影剂定量主动脉夹层假管腔血栓形成的新方法。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: False lumen thrombosis after aortic dissection is a major predictor of prognosis. First pass computed tomography (CT) and magnetic resonance (MR) imaging are used routinely, where the image acquisition is timed to the arrival of contrast in the proximal unaffected aorta. Delayed phase imaging is difficult to refine because flow rates in the false lumen are often very slow and highly variable between patients. Blood pool contrast agents bind to albumin and become homogenously distributed in the intravascular circulation, allowing accurate imaging of areas where flow is low. We compared first pass MR and CT with a delayed phase MR acquisition using a blood pool agent to assess whether this more accurately quantified false lumen thrombosis. METHODS: Patients with medically treated chronic type B aortic dissection and evidence of false lumen thrombosis on previous CT imaging underwent first pass CT, first pass MR, and delayed phase MR with blood pool agent. Absence of false lumen contrast enhancement was quantified to assess the apparent differences in thrombosis. Phase-contrast MR data were also obtained to assess the affect of flow velocity on false lumen contrast enhancement, and direct thrombus MR images were used to confirm the presence of thrombus. RESULTS: Twelve patients were recruited. No difference was seen in apparent thrombus volume between first pass CT and first pass MR imaging (146.9 cm(3) [SD, 88.6] vs 187.6 cm(3) [SD, 136.1], P = .1119; R(2) = .67 [95% confidence interval (CI), r = .46-.95], P = .0012). In all patients, the volume of thrombus derived from first pass acquisitions was greater than the volume derived from delayed phase MR imaging with blood pool agent: first pass CT (paired t test, P = .0007; mean difference = 83.4 cm(3) [95% CI, 44.1-122.6]) and first pass MR (paired t test, P = .0009; mean difference = 124.0 cm(3) [95% CI, 63.2-184.9]). The difference in thrombus volume between first pass and delayed phase MR imaging with blood pool agent correlated significantly with the mean velocity of flow in the false lumen, with lower flow related to a greater difference (R(2) = .61, P = .0028 [95% CI, r = -.94--.37]). Direct thrombus MR images were able to correctly discriminate between thrombus and blood and matched the area of contrast absence on delayed phase MR with blood pool agent images. CONCLUSION: First pass techniques to assess false lumen thrombosis in aortic dissection consistently overestimate the apparent thrombus volume by five to six times. This has implications for interpretation of cohort studies and clinical trials that use false lumen thrombosis as an outcome measure. We recommend delayed phase MR imaging with a blood pool agent when accurate assessment of false lumen thrombosis is required.
机译:背景:主动脉夹层术后假性内腔血栓形成是预后的主要预测指标。通常使用首过计算机断层扫描(CT)和磁共振(MR)成像,其中图像采集的时间要与近端未受影响主动脉中造影剂的到达时间同步。延迟相成像很难完善,因为假管腔中的流速通常非常缓慢且患者之间变化很大。血池造影剂与白蛋白结合并在血管内循环中均匀分布,从而可以对流量低的区域进行精确成像。我们将首次通过的MR和CT与使用血池药剂的延迟MR采集进行了比较,以评估这种方法能否更准确地量化假管腔血栓形成。方法:对患有慢性B型主动脉夹层的药物治疗并在先前CT成像中发现假管腔血栓形成的患者,先行通过CT,先行MR和延迟期MR,并采用血池造影剂。量化假管腔对比增强的缺失,以评估血栓形成的明显差异。还获得相衬MR数据,以评估流速对假管腔对比度增强的影响,并使用直接血栓MR图像确认血栓的存在。结果:招募了12名患者。首次通过CT和首次通过MR成像之间的血栓体积无明显差异(146.9 cm(3)[SD,88.6]与187.6 cm(3)[SD,136.1],P = .1119; R(2)= 0.67 [95%置信区间(CI),r = .46-.95],P = 0.0012)。在所有患者中,首次通过血栓采集的血栓量大于使用血池试剂的延迟MR成像产生的血栓量:首次通过CT(配对t检验,P = 0.0007;平均差= 83.4 cm(3) [95%CI,44.1-122.6])和首过MR(配对t检验,P = .0009;平均差= 124.0 cm(3)[95%CI,63.2-184.9])。初次和延迟期MR成像与血池剂之间的血栓量差异与假管腔中的平均流速显着相关,而流速越低则差异越大(R(2)= .61,P =。 0028 [95%CI,r = -.94-。37])。直接血栓MR图像能够正确地区分血栓和血液,并将延迟期MR的造影剂缺失区域与血池剂图像匹配。结论:评估主动脉夹层假管腔血栓形成的首过技术一贯高估了表观血栓量五至六倍。这对使用假内腔血栓形成作为结果指标的队列研究和临床试验的解释具有意义。当需要准确评估假管腔血栓形成时,我们建议使用血池药进行延迟MR成像。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号